Israel’s Health Ministry Implements Strict New Rules for Opioid Prescriptions
Updated guidelines from the Ministry of Health regulating the distribution of opioid painkillers have officially taken effect in Israel. While these medications are prescribed to manage severe pain, they carry significant risks: uncontrolled use can lead to severe addiction, damage to the central nervous system, and even fatal overdoses.
To mitigate the risk of abuse, the ministry has significantly reduced the validity period of paper prescriptions. Effective immediately, opioid prescriptions are valid for only five days, down from the previous 15-day window. Furthermore, the quantity of medication dispensed per prescription is now strictly capped at a maximum five-day supply.
The regulatory overhaul also impacts where these medications can be purchased. The dispensing of such drugs is now restricted to pharmacies integrated into the unified computer network of the national health maintenance organizations (HMOs). This integration allows physicians to monitor prescription histories in real time, effectively preventing “doctor shopping”—situations where individuals obtain prescriptions for controlled substances from multiple sources.
The ministry is also spearheading a gradual transition to secure digital prescriptions, which are virtually impossible to forge. An additional mandate has been introduced for private practitioners: they are now required to notify patients in advance that the details of their prescribed painkillers will be automatically reported to their respective HMO.
Health officials emphasize that these heightened controls are designed solely to protect public health and prevent addiction. Patients with legitimate medical needs for these medications will continue to receive their necessary treatments without hindrance.
